Tuesday, August 04, 2009 9:29:54 PM
August 4, 2009 by MassDevice staff
Billerica, Mass.-based imaging equipment maker CEO Frank Laukien boosts his stake in the company to 23.4 percent.
Laukien family members may sell some of their Bruker Corp. stock from time to time, but it doesn't seem to stay away for long.
Less than two months after his mother and two siblings disclosed plans to unload a large chunk of their stake, CEO Frank Laukien bought up another 150,000 shares in the Billerica, Mass.-based medical imaging equipment manufacturer from outside investors, according to filings with the federal Securities and Exchange Commission.
Laukien made the purchases — $1.51 million worth of stock at an average price of $10.03 — via a series of small transactions July 31 and August 3. The latest buying spree follows a familiar Laukien pattern established in recent years: They sell and he buys, although not necessarily from each other.
Since last November, Frank Laukien has spent close to $7.5 million of his own funds to acquire an additional 1.6 million shares. He now owns 38,449,445 shares, or roughly 23.4 percent of the company.
Other Laukien family members control another 45 percent of Bruker stock. That combined stake, however, would dip to roughly 22.5 percent if the company moves ahead with a proposed secondary offering that includes the sale of 35 million shares now held by Isolde Laukien-Kleiner and Dirk and Marc Laukien.
Frank Laukien's recent purchases came through open-market deals, rather than the exercising of options or other stock awards. He was also a significant player in overall trading of Bruker stock during the past few days, accounting for 14 percent of total volume on Friday and Monday.
One reason might be Bruker Corp.'s rather stingy ways with option grants. Frank Laukien holds vested options to buy a total of 175,000 shares — with only 75,000 of those options priced below Monday's closing price of $10.09, according to company proxy statements.
http://www.massdevice.com/news/bruker-ceo-ups-stake
Recent BRKR News
- Bruker to Acquire the NanoString Business in an Asset Deal • Business Wire • 04/22/2024 11:00:00 AM
- Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates • Business Wire • 04/08/2024 11:00:00 AM
- Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies • Business Wire • 04/08/2024 11:00:00 AM
- Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research • GlobeNewswire Inc. • 04/04/2024 12:11:00 PM
- Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook • Business Wire • 04/01/2024 11:00:00 AM
- Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO • Business Wire • 03/11/2024 11:00:00 AM
- Bruker Announces Closing of Chemspeed Technologies AG Acquisition • Business Wire • 03/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:05:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:28:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 08:58:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 10:43:46 PM
- Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup • Business Wire • 02/28/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:02:18 PM
- Bruker Corporation to Present at Upcoming Investor Conferences • Business Wire • 02/26/2024 03:42:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 11:01:18 PM
- Bruker Announces Quarterly Dividend • Business Wire • 02/16/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:04:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 12:39:09 PM
- Bruker Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/13/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 12:02:17 PM
- Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience • Business Wire • 02/07/2024 12:00:00 PM
- Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems • Business Wire • 02/06/2024 09:05:00 PM
- Bruker Announces Date and Time of Fourth Quarter 2023 Earnings Release and Webcast • Business Wire • 02/06/2024 12:00:00 PM
- Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024 • Business Wire • 02/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:38:52 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM